Induction Healthcare Group PLC announced the following Board changes. Ian Johnson has been appointed to the Board as the Senior Independent Director replacing Leslie-Ann Reed who will be stepping down following completion of her three-year term. Andy Williams is also appointed Chair of the Audit Committee.

Guy Mitchell has resigned as a Director with immediate effect, but will remain with the business for a short handover period. Ian Johnson appointed as Senior Independent Director: Ian brings over 30 years of Board experience working with quoted and private companies in the Life Sciences space, having spent a career providing strategic direction and business development expertise. He has a proven track record of overseeing business growth and providing commercial advice through scale-up, organic growth and M&A activity.

Ian is currently Executive Chairman of NIOX Group plc, a business focused on improving asthma diagnosis and management. In addition, Ian is Operational Adviser at Harwood Private Equity focusing on the Life Sciences sector. He was founder and CEO of Biotrace International Plc before its sale to 3M in December 2006 and has previously been SID of Clinigen plc.

Ian has also acted as Executive Chairman for Bioquell PLC, Non-Executive Chairman of Quantum Pharma plc,Cyprotex PLC, Biofortuna Limited and Celsis Groupand Non-Executive Director of Ergomed PLC.